Patent details

Basic Information

Publication number:

EP2258430

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP100753813

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

5-(Aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide and its use in medicine

French Title of Invention:

5-(Aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide et son utlisation en médecine

German Title of Invention:

5-(Aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide und dessen medizinische Verwendung

SPC Number:

Dates

Filing date:

29/12/2006

Grant date:

22/03/2017

EP Publication Date:

08/12/2010

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/03/2017

EP B1 Publication Date:

22/03/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/12/2017

Expiration date:

29/12/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/03/2017

 

 

Name:

Morvus Technology Ltd.

Address:

Llanvetherine Court, Abergavenny NP7 8NL, United Kingdom (GB)

Inventor

Name:

Knox, Richard John

Address:

United Kingdom (GB)

Priority

Priority Number:

0526552

Priority Date:

29/12/2005

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61K 31/04; A61K 31/045; A61K 31/12; A61K 31/396; A61K 45/06; A61M 11/00; A61M 15/00; B05B 11/00; C07B 31/00; C07D 203/14;

Publication

European Patent Bulletin

Issue number:

201712

Publication date:

22/03/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/04/2018	Outgoing Correspondence	1